Key Financial Data Of Reporting Company

COSMOS Pharmaceutical Corporation - Filing #7590008

Concept 2021-06-01 to
2022-05-31
2021-06-01 to
2022-05-31
As at
2022-05-31
As at
2022-05-31
2020-06-01 to
2021-05-31
As at
2021-05-31
2020-06-01 to
2021-05-31
As at
2021-05-31
2019-06-01 to
2020-05-31
As at
2020-05-31
As at
2020-05-31
2019-06-01 to
2020-05-31
2018-06-01 to
2019-05-31
As at
2019-05-31
As at
2019-05-31
2018-06-01 to
2019-05-31
2017-06-01 to
2018-05-31
2017-06-01 to
2018-05-31
As at
2018-05-31
As at
2018-05-31
Key financial data of reporting company
Business results of reporting company
Net sales
755,414,000,000 JPY
755,413,000,000 JPY
726,424,000,000 JPY
726,423,000,000 JPY
684,403,000,000 JPY
684,402,000,000 JPY
611,137,000,000 JPY
611,136,000,000 JPY
557,999,000,000 JPY
557,997,000,000 JPY
Ordinary profit (loss)
32,861,000,000 JPY
32,839,000,000 JPY
35,835,000,000 JPY
35,817,000,000 JPY
31,562,000,000 JPY
31,544,000,000 JPY
27,292,000,000 JPY
27,262,000,000 JPY
25,255,000,000 JPY
25,237,000,000 JPY
Profit (loss)
23,141,000,000 JPY
27,145,000,000 JPY
21,423,000,000 JPY
19,165,000,000 JPY
17,622,000,000 JPY
Share capital
4,178,000,000 JPY
4,178,000,000 JPY
4,178,000,000 JPY
4,178,000,000 JPY
4,178,000,000 JPY
Total number of issued shares
40,000,800 xbrli:shares
40,000,800 xbrli:shares
20,000,400 xbrli:shares
20,000,400 xbrli:shares
20,000,400 xbrli:shares
Net assets
190,507,000,000 JPY
190,106,000,000 JPY
170,578,000,000 JPY
170,235,000,000 JPY
145,366,000,000 JPY
145,675,000,000 JPY
126,289,000,000 JPY
126,021,000,000 JPY
108,638,000,000 JPY
108,888,000,000 JPY
Total assets
363,052,000,000 JPY
362,630,000,000 JPY
341,318,000,000 JPY
340,892,000,000 JPY
319,854,000,000 JPY
320,283,000,000 JPY
273,561,000,000 JPY
273,130,000,000 JPY
250,213,000,000 JPY
250,609,000,000 JPY
Net assets per share
4,810.92
4,800.79
4,307.63
4,298.96
3,670.96
3,678.76
3,189.19
3,182.43
5,486.90
5,499.55
Dividend paid per share
80.00
70.00
110.00
100.00
90.00
Interim dividend paid per share
40.00
27.50
50.00
45.00
45.00
Basic earnings (loss) per share
584.76
584.40
685.80
685.52
541.30
541.01
484.48
484.00
890.59
890.05
Diluted earnings per share
Equity-to-asset ratio
0.525 xbrli:pure
0.524 xbrli:pure
0.500 xbrli:pure
0.499 xbrli:pure
0.454 xbrli:pure
0.455 xbrli:pure
0.462 xbrli:pure
0.461 xbrli:pure
0.434 xbrli:pure
0.434 xbrli:pure
Rate of return on equity
0.128 xbrli:pure
0.128 xbrli:pure
0.172 xbrli:pure
0.172 xbrli:pure
0.158 xbrli:pure
0.158 xbrli:pure
0.163 xbrli:pure
0.163 xbrli:pure
0.175 xbrli:pure
0.175 xbrli:pure
Price-earnings ratio
20.9 xbrli:pure
20.9 xbrli:pure
22.2 xbrli:pure
22.2 xbrli:pure
28.6 xbrli:pure
28.6 xbrli:pure
17.7 xbrli:pure
17.7 xbrli:pure
26.3 xbrli:pure
26.4 xbrli:pure
Payout ratio
0.137 xbrli:pure
0.102 xbrli:pure
0.102 xbrli:pure
0.103 xbrli:pure
0.101 xbrli:pure
Net cash provided by (used in) operating activities
32,194,000,000 JPY
27,875,000,000 JPY
65,461,000,000 JPY
34,379,000,000 JPY
32,586,000,000 JPY
Net cash provided by (used in) investing activities
-43,717,000,000 JPY
-19,381,000,000 JPY
-26,956,000,000 JPY
-30,042,000,000 JPY
-30,458,000,000 JPY
Net cash provided by (used in) financing activities
-6,222,000,000 JPY
-5,507,000,000 JPY
-5,405,000,000 JPY
-6,982,000,000 JPY
-8,188,000,000 JPY
Cash and cash equivalents
37,362,000,000 JPY
55,108,000,000 JPY
52,122,000,000 JPY
19,022,000,000 JPY
21,668,000,000 JPY
Number of employees
5,101 xbrli:pure
5,093 xbrli:pure
4,872 xbrli:pure
4,864 xbrli:pure
4,378 xbrli:pure
4,386 xbrli:pure
4,240 xbrli:pure
4,232 xbrli:pure
3,841 xbrli:pure
3,849 xbrli:pure
Average number of temporary employees
17,199 xbrli:pure
17,156 xbrli:pure
16,167 xbrli:pure
16,122 xbrli:pure
14,628 xbrli:pure
14,678 xbrli:pure
13,441 xbrli:pure
13,388 xbrli:pure
12,142 xbrli:pure
12,199 xbrli:pure
Total shareholder return
1.070 xbrli:pure
1.322 xbrli:pure
1.337 xbrli:pure
0.742 xbrli:pure
1.008 xbrli:pure
Total return on share price index
1.369 xbrli:pure
1.344 xbrli:pure
1.070 xbrli:pure
1.008 xbrli:pure
1.138 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.